Physician profile
Adam Griffith
NPI 1659891745
$13,472.22
in general payments reported to CMS, 2019-2025
11 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2021: $1,200 · 2022: $2,788 · 2023: $7,128 · 2024: $818 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,894 · Food and Beverage: $2,677 · Education: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,894.34 |
| Food and Beverage | $2,677.45 |
| Education | $2,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,681.35 | 2022-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Acufex Director, Real Intelligence |
| Peerless Surgical INC. | $3,700.63 | 2019-2023 | |
| Stryker Corporation | $1,636.90 | 2023-2024 | Mako, Aequalis Perform, Triathlon |
| Arthrex, INC. | $1,146.47 | 2023 | |
| Exactech, INC. | $441.64 | 2023 | |
| Vericel Corporation | $284.93 | 2022-2024 | Maci |
| Medacta USA, INC. | $264.40 | 2024-2025 | Gmk Sphere |
| Depuy Synthes Sales INC. | $120.05 | 2023-2024 | Na, Truespan Orthocord, Dynacord |
| Si-Bone, INC. | $97.24 | 2022 | |
| Fx Shoulder Solutions, INC | $78.61 | 2025 | |
| Shoulder Innovations, INC. | $20.00 | 2024 | Inset System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.